期刊文献+

阿替普酶与大秦艽汤治疗急性脑梗死疗效研究 被引量:3

Effect of alteplase and Daqin gentiana Decoction on acute cerebral infarction
下载PDF
导出
摘要 目的分析急性脑梗死患者行阿替普酶与大秦艽汤联合治疗的效果。方法选择2015年1月~2017年2月就诊的68例急性脑梗死患者,按照随机数字表法分为阿替普酶治疗的对照组与联合大秦艽汤治疗的观察组,对比分析两组的治疗效果。结果在临床治疗总有效率方面,观察组与对照组分别为94.12%与79.41%,两组差异有统计学意义(P<0.05);在不良反应发生率方面,观察组与对照组分别为8.82%与17.65%,差异有统计学意义(P<0.05)。结论急性脑梗死患者选择阿替普酶与大秦艽汤联合治疗,不仅能够显著提高治疗效果,且安全性高。 Objective To analyze the effect of combination therapy of alteplase and Daqin gentiana Decoction in patients with acute cerebral infarction.Methods 68 cases of patients with acute cerebral infarction who were treated in our hospital from January 2015 to February 2017 were divided into two groups:the control group treated with alteplase and the observation group treated with alteplase and Daqinjiao Decotion.The effect of the two groups of treatment were analyzed.Results In the total effective rate of clinical treatment,the observation group and the control group were 94.12%and 79.41%.The difference between the two groups was significant(P<0.05);in the incidence of adverse reactions,the observation group and the control group were 8.82%And 17.65%.The difference between the two groups was significant(P<0.05).Conclusion The combination of alteplase and Daqing Gentiana decoction in patients with acute cerebral infarction can not only improve the therapeutic effect,but also have high safety.
作者 宋晶晶 SONG Jingjing(Yuncheng County TCM Hospital,Heze 274700,China)
机构地区 郓城县中医医院
出处 《中国处方药》 2018年第4期46-47,共2页 Journal of China Prescription Drug
关键词 阿替普酶 大秦艽汤 急性脑梗死 Alteplase Daqin gentiana Decoction Acute cerebral infarction
  • 相关文献

参考文献15

二级参考文献114

  • 1李剑鹏,马琪林,童绥君,曲红丽,鲁丛霞,黄远亮.颈内动脉系统脑梗死3~6h静脉溶栓与动脉溶栓的比较[J].中国实用神经疾病杂志,2010,13(23):3-6. 被引量:7
  • 2肖淑萍,朱海英.局部亚低温对脑梗死患者血清IL-8和细胞间粘附分子-1的影响[J].临床医学,2006,26(5):67-68. 被引量:2
  • 3Fulgham JR,Ingall TJ,Stead LG,et al.Manage of acute ischemic stroke[J].Mayo Clin Pro,2004,79(11):1459-1469.
  • 4The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group.Tissue plasminogen activator for acute ischemic stroke[J].N Engl J Med,1995,333(24):1581-1587.
  • 5Bluhmki E,Chamorro A,Dávalos A,et al.Stroke treatment with alteplase given 3.0-4.5 h after onset of acute ischaemic stroke (ECASS Ⅲ):additional outcomes and subgroup analysis of a randomised controlled trial[J].Lancet Neurol,2009,8(12):1095-1102.
  • 6Albers GW,Amarenco P,Easton JD,et al.Antithrombotic and thrombolytic therapy for ischemic stroke:American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)[J].Chest,2008,133(6 suppl):630s-669s.
  • 7The International Stroke Trial (IST).A randomize trial of aspirin,subcutaneous heparin,both,or neither among 19 435 patients with acute ischaemi stroke.International Stroke Trial Collaborative Group[J].Lancet,1997,349(9065):1569-1581.
  • 8CAST(Chinese Acute Stroke Trial) Collaborative Group.Randomised placebo-controlled trial of early aspirin use in 20 000 patients with acute ischaemic[J].Lancet,1997,349(9066):1641-1649.
  • 9Alexandrov AV,Grotta JC.Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator[J].Neurology,2002,59(6):862-867.
  • 10Straub S,Junghans U,Jovanovic V,et al.Systemic thrombolysis with recombinant tissue plasminogen activator and tirofiban in acute middle cerebral artery occlusion[J].Stroke,2004,35:705-709.

共引文献507

同被引文献35

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部